mp0317
Recombinant proteinexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 11, 2021 (NCT05098405)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07036380 | Phase 2 | Jun 30, 2025 | CHU Besançon, Molecular Partners AG, University of Franche-Comté |
| NCT05098405 | Phase 1 | Oct 11, 2021 | Molecular Partners AG |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Molecular Partners AG | For profit | 2 | 1 | 2 | 2021 |
| CHU Besançon | Academic/Hospital | 1 | 0 | 1 | 2025 |
| University of Franche-Comté | Academic/Hospital | 1 | 1 | 1 | 2025 |
3 organizations
Page 1 / 1